<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, or slow <z:chebi fb="0" ids="16990">bilirubin</z:chebi> glucuronidation phenotype, is a common cause of benign <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> in the general population </plain></SENT>
<SENT sid="1" pm="."><plain>There have been only two previously reported cases of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> occurring in patients after liver transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>This study was conducted to determine the frequency of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in liver transplant recipients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The charts of <z:hpo ids='HP_0000001'>all</z:hpo> patients followed by the Mayo Liver Transplant Clinic for 1 yr or more after transplantation, as of June 1992, were reviewed to identify <z:hpo ids='HP_0000001'>all</z:hpo> patients with a consistent pattern of <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> greater than two times the upper limits of <z:mpath ids='MPATH_458'>normal</z:mpath> and with a <z:mpath ids='MPATH_458'>normal</z:mpath> conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> level </plain></SENT>
<SENT sid="4" pm="."><plain>These patients were further evaluated to exclude <z:hpo ids='HP_0000001'>all</z:hpo> other causes of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, including <z:e sem="disease" ids="C0400979" disease_type="Disease or Syndrome" abbrv="">biliary obstruction</z:e>, rejection, <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:hpo ids='HP_0002611'>cholestatic liver disease</z:hpo>, and <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Five of 229 patients (2.2%) had a consistent pattern of <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Only three patients (1.3%) had no other identifiable cause of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This study was performed to determine the incidence of <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> and particularly to determine the incidence of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> in liver transplant recipients </plain></SENT>
<SENT sid="8" pm="."><plain>The apparently low frequency of Gilbert's after liver transplantation may reflect the masking of the diagnosis by other transplant-associated pathology or donor selection bias because of unexplained <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Post-transplant patients who fit the <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> profile of <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> should have a postprandial <z:chebi fb="0" ids="16990">bilirubin</z:chebi> drawn as a first step </plain></SENT>
<SENT sid="10" pm="."><plain>The awareness of this syndrome may avoid a costly and invasive evaluation in the liver transplant recipient </plain></SENT>
</text></document>